|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Moore MA, Eser S, Igisinov N, Igisinov S,
Mohagheghi MA, Mousavi-Jarrahi A, Ozentürk G, Soipova M, Tuncer M
and Sobue T: Cancer epidemiology and control in North-Western and
Central Asia-past, present and future. Asian Pac J Cancer Prev. 11
(Suppl 2):S17–S32. 2010.
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Apicella M, Corso S and Giordano S:
Targeted therapies for gastric cancer: Failures and hopes from
clinical trials. Oncotarget. 8:57654–57669. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun L, Wang H, Wang Z, He S, Chen S, Liao
D, Wang L, Yan J, Liu W, Lei X and Wang X: Mixed lineage kinase
domain-like proteinmediates necrosis signaling downstream of RIP3
kinase. Cell. 148:213–227. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q,
Luo J and Liu ZG: Mixed lineage kinase domain-like is a key
receptor interacting protein 3 downstream component of TNF-induced
necrosis. Proc Natl Acad Sci USA. 109:5322–5327. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vanlangenakker N, Vanden Berghe T and
Vandenabeele P: Many stimuli pull the necrotic trigger, an
overview. Cell Death Differ. 19:75–86. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tenev T, Bianchi K, Darding M, Broemer M,
Langlais C, Wallberg F, Zachariou A, Lopez J, MacFarlane M, Cain K
and Meier P: The ripoptosome, a signaling platform that assembles
in response to genotoxic stress and loss of IAPs. Mol Cell.
43:432–448. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Coupienne I, Fettweis G and Piette J: RIP3
expression induces a death profile change in U2OS osteosarcoma
cells after 5-ALA-PDT. Lasers Surg Med. 43:557–564. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chu WM: Tumor necrosis factor. Cancer
Lett. 328:222–225. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zong WX and Thompson CB: Necrotic death as
a cell fate. Genes Dev. 20:1–15. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou Z, Han V and Han J: New components of
the necroptotic pathway. Protein Cell. 3:811–817. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Paulsen RD, Soni DV, Wollman R, Hahn AT,
Yee MC, Guan A, Hesley JA, Miller SC, Cromwell EF, Solow-Cordero
DE, et al: A genome-wide siRNA screen reveals diverse cellular
processes and pathways that mediate genome stability. Mol Cell.
35:228–239. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ruan J, Mei L, Zhu Q, Shi G and Wang H:
Mixed lineage kinase domain-like protein is a prognostic biomarker
for cervical squamous cell cancer. Int J Clin Exp Pathol.
8:150352015.PubMed/NCBI
|
|
15
|
He L, Peng K, Liu Y, Xiong J and Zhu FF:
Low expression of mixed lineage kinase domain-like protein is
associated with poor prognosis in ovarian cancer patients. Onco
Targets Ther. 6:1539–1543. 2013.PubMed/NCBI
|
|
16
|
Colbert LE, Fisher SB, Hardy CW, Hall WA,
Saka B, Shelton JW, Petrova AV, Warren MD, Pantazides BG, Gandhi K,
et al: Pronecrotic mixed lineage kinase domain-like protein
expression is a prognostic biomarker in patients with early-stage
resected pancreatic adenocarcinoma. Cancer. 119:3148–3155. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li X, Guo J, Ding AP, Qi WW, Zhang PH, Lv
J, Qiu WS and Sun ZQ: Association of mixed lineage kinase
domain-like protein expression with prognosis in patients with
colon cancer. Technol Cancer Res Treat. 16:428–434. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ajani JA In H and Sano T: Stomach. AJCC
Cancer Staging Manual. Amin MB. 8th. Springer-Verlag; New York, NY:
2016
|
|
19
|
Xue Y, Ma G, Gu D, Zhu L, Hua Q, Du M, Chu
H, Tong N, Chen J, Zhang Z and Wang M: Genome-wide analysis of long
noncoding RNA signature in human colorectal cancer. Gene.
556:227–234. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ertao Z, Jianhui C, Kang W, Zhijun Y, Hui
W, Chuangqi C, Changjiang Q, Sile C, Yulong H and Shirong C:
Prognostic value of mixed lineage kinase domain-like protein
expression in the survival of patients with gastric caner. Tumor
Biol. 37:13679–13685. 2016. View Article : Google Scholar
|
|
22
|
Vandenabeele P, Galluzzi L, Vanden Berghe
T and Kroemer G: Molecular mechanisms of necroptosis: An ordered
cellular explosion. Nat Rev Mol Cell Biol. 11:700–714. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Krysko O, Aaes TL, Kagan VE, D'Herde K,
Bachert C, Leybaert L, Vandenabeele P and Krysko DV: Necroptotic
cell death in anti-cancer therapy. Immunol Rev. 280:207–219. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang H, Sun L, Su L, Rizo J, Liu L, Wang
LF, Wang FS and Wang X: Mixed lineage kinase domain-like protein
MLKL causes necrotic membrane disruption upon phosphorylation by
RIP3. Mol Cell. 54:133–146. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dondelinger Y, Declercq W, Montessuit S,
Roelandt R, Goncalves A, Bruggeman I, Hulpiau P, Weber K, Sehon CA,
Marquis RW, et al: MLKL compromises plasma membrane integrity by
binding to phosphatidylinositol phosphates. Cell Rep. 7:971–981.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu Y, Cui H, Gan H, Xia Y, Wang L, Wang Y
and Sun Y: Necroptosis mediated by receptor interaction protein
kinase 1 and 3 aggravates chronic kidney injury of subtotal
nephrectomised rats. Biochem Biophys Res Commun. 461:575–581. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Moriwaki K and Chan FK: RIP3: A molecular
switch for necrosis and inflammation. Genes Dev. 27:1640–1649.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pasparakis M and Vandenabeele P:
Necroptosis and its role in inflammation. Nature. 517:311–320.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Alderson NL, Rembiesa BM, Walla MD,
Bielawska A, Bielawski J and Hama H: The human FA2H gene encodes a
fatty acid 2-hydroxylase. J Biol Chem. 279:48562–48568. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Alderson NL, Walla MD and Hama H: A novel
method for the measurement of in vitro fatty acid 2-hydroxylase
activity by gaschromatography-mass spectrometry. J Lipid Res.
46:1569–1575. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Herrero AB, Astudillo AM, Balboa MA,
Cuevas C, Balsinde J and Moreno S: Levels of SCS7/FA2H-mediated
fatty acid 2-hydroxylation determine the sensitivity of cells to
antitumor PM02734. Cancer Res. 68:9779–9787. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Takeda S, Ikeda E, Su S, Harada M, Okazaki
H, Yoshioka Y, Nishimura H, Ishii H, Kakizoe K, Taniguchi A, et al:
Δ(9)-THC modulation of fatty acid 2-hydroxylase (FA2H) gene
expression: Possible involvement of induced levels of PPARα in
MDA-MB-231 breast cancer cells. Toxicology. 326:18–24. 2014.
View Article : Google Scholar : PubMed/NCBI
|
